Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) (N-Term) Peptide
Our Local Distributor
北京 101111
Quick Overview for Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) (N-Term) Peptide (ABIN8096953)
抗原
资源
应用范围
-
-
蛋白结构域
- N-Term
-
原理
- CHRNA3 Peptide - N-terminal region
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti-CHRNA3 antibody ( ARP34964_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
-
背景
-
Targeted Subunit: alpha-3
Background Information: The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
Alternative Symbols: MGC104879, LNCR2, PAOD2, NACHRA3
-
分子量
- 57kDa
-
基因ID
- 1136
-
NCBI登录号
- NP_000734
-
UniProt
- P32297
抗原
-